Key facts
- Microcaps’s last known valuation is $45.3M.
- It has raised $15.9M; the latest was Later Stage VC ($10.2M) in Jun 2024.
- Notable investors include MassChallenge, Venture Kick, Zürcher Kantonalbank, Venture (Switzerland), ETH Zürich Foundation — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Microcaps
- ·The full record, as it builds
Funding rounds
No funding rounds for Microcaps are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Microcaps
Developer of a microencapsulation technology intended to protect pharmaceutical agents in drugs or fragrances in cosmetic products. The company offers a method to create liquid oil core microcapsules with a natural alginate shell and increase controlled microencapsulation production compared to conventional processes via a step emulsification device, enabling clients to achieve higher throughput rates without quality loss.
- Sector
- Materials and Resources
- HQ
- Schlieren, Switzerland
- Founded
- 2018
- Employees
- 31
- Website
- microcaps.ch/
- Ownership
- Privately Held (backing)
Microcaps doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Microcaps shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Microcaps in its N-PORT filings yet. We sweep new filings monthly.